Trajectory of Immunosuppression-Caused Tremor In Kidney Transplant Recipients
Launched by UNIVERSITY MEDICAL CENTER GRONINGEN · Jul 3, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of certain medications used by kidney transplant recipients (KTR) that can cause tremors, which are involuntary shaking movements in the limbs, head, or body. These medications, known as calcineurin inhibitors (like cyclosporine and tacrolimus), are crucial for preventing the body from rejecting the new kidney, but they can lead to side effects, including tremors. Researchers want to understand how these tremors change over time after a kidney transplant, as it's currently unclear if they get better or worse as treatment continues.
To participate in this study, individuals must be at least 16 years old and scheduled to receive a kidney transplant. Participants will be asked to complete questionnaires and tests to assess their tremors. This research aims to provide valuable insights into how tremors develop and change after transplantation, which could help in managing these side effects and improving support for patients in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients ≥ 16 years old, who will receive a kidney transplant
- Exclusion Criteria:
- • patients who are unable to comprehend the questionnaires and tests
About University Medical Center Groningen
University Medical Center Groningen (UMCG) is a leading academic medical center in the Netherlands, renowned for its commitment to innovative research, high-quality patient care, and extensive education in the medical field. As a prominent sponsor of clinical trials, UMCG leverages its multidisciplinary expertise and state-of-the-art facilities to advance medical knowledge and improve therapeutic outcomes. The center fosters collaboration among researchers, healthcare professionals, and industry partners, aiming to translate scientific discoveries into effective treatments that enhance patient health and well-being. With a focus on ethical standards and regulatory compliance, UMCG is dedicated to conducting clinical trials that contribute to the advancement of medicine and the betterment of society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Groningen, , Netherlands
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported